Selected research
Industry Research
Hospital and Nursing Home Probiotics Industry Research Report 2026
Market perspective
The global Hospital and Nursing Home Probiotics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hospital and Nursing Home Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hospital and Nursing Home Probiotics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hospital and Nursing Home Probiotics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hospital and Nursing Home Probiotics include American Lifeline, Becton Dickinson and Company, Bio - K Plus International, Eva Nutra, Mercola, Nebraska Cultures, Nutraceutix, NutraScience Labs and Probium, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hospital and Nursing Home Probiotics market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hospital and Nursing Home Probiotics Market by Company
American Lifeline
Becton Dickinson and Company
Bio - K Plus International
Eva Nutra
Mercola
Nebraska Cultures
Nutraceutix
NutraScience Labs
Probium
Protexin
Rising Pharmaceuticals
UP4 Probiotics
Vitakem Nutraceuticals
Hospital and Nursing Home Probiotics Segment by Type
Gram-positive Cocci
Lactobacillus
Bifidobacterium
Others
Hospital and Nursing Home Probiotics Segment by Application
Immunity
Wellness
Gut Health
Others
Hospital and Nursing Home Probiotics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hospital and Nursing Home Probiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hospital and Nursing Home Probiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hospital and Nursing Home Probiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hospital and Nursing Home Probiotics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hospital and Nursing Home Probiotics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hospital and Nursing Home Probiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gram-positive Cocci
- Lactobacillus
- Bifidobacterium
- Others
Applications
- Immunity
- Wellness
- Gut Health
- Others
Companies covered
- American Lifeline
- Becton Dickinson and Company
- Bio - K Plus International
- Eva Nutra
- Mercola
- Nebraska Cultures
- Nutraceutix
- NutraScience Labs
- Probium
- Protexin
- Rising Pharmaceuticals
- UP4 Probiotics
- Vitakem Nutraceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hospital and Nursing Home Probiotics Market Size (2021-2032)
- 2.2.2 Global Hospital and Nursing Home Probiotics Sales (2021-2032)
- 2.2.3 Global Hospital and Nursing Home Probiotics Market Average Price (2021-2032)
- 2.3 Hospital and Nursing Home Probiotics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Gram-positive Cocci
- 2.3.3 Lactobacillus
- 2.3.4 Bifidobacterium
- 2.3.5 Others
- 2.4 Hospital and Nursing Home Probiotics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Immunity
- 2.4.3 Wellness
- 2.4.4 Gut Health
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hospital and Nursing Home Probiotics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hospital and Nursing Home Probiotics Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Hospital and Nursing Home Probiotics Revenue of Manufacturers (2021-2026)
- 3.4 Global Hospital and Nursing Home Probiotics Average Price by Manufacturers (2021-2026)
- 3.5 Global Hospital and Nursing Home Probiotics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hospital and Nursing Home Probiotics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hospital and Nursing Home Probiotics, Product Type & Application
- 3.8 Global Manufacturers of Hospital and Nursing Home Probiotics, Established Date
- 3.9 Global Hospital and Nursing Home Probiotics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 American Lifeline
- 4.1.1 American Lifeline Company Information
- 4.1.2 American Lifeline Business Overview
- 4.1.3 American Lifeline Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 American Lifeline Hospital and Nursing Home Probiotics Product Portfolio
- 4.1.5 American Lifeline Recent Developments
- 4.2 Becton Dickinson and Company
- 4.2.1 Becton Dickinson and Company Company Information
- 4.2.2 Becton Dickinson and Company Business Overview
- 4.2.3 Becton Dickinson and Company Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Becton Dickinson and Company Hospital and Nursing Home Probiotics Product Portfolio
- 4.2.5 Becton Dickinson and Company Recent Developments
- 4.3 Bio - K Plus International
- 4.3.1 Bio - K Plus International Company Information
- 4.3.2 Bio - K Plus International Business Overview
- 4.3.3 Bio - K Plus International Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bio - K Plus International Hospital and Nursing Home Probiotics Product Portfolio
- 4.3.5 Bio - K Plus International Recent Developments
- 4.4 Eva Nutra
- 4.4.1 Eva Nutra Company Information
- 4.4.2 Eva Nutra Business Overview
- 4.4.3 Eva Nutra Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Eva Nutra Hospital and Nursing Home Probiotics Product Portfolio
- 4.4.5 Eva Nutra Recent Developments
- 4.5 Mercola
- 4.5.1 Mercola Company Information
- 4.5.2 Mercola Business Overview
- 4.5.3 Mercola Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Mercola Hospital and Nursing Home Probiotics Product Portfolio
- 4.5.5 Mercola Recent Developments
- 4.6 Nebraska Cultures
- 4.6.1 Nebraska Cultures Company Information
- 4.6.2 Nebraska Cultures Business Overview
- 4.6.3 Nebraska Cultures Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Nebraska Cultures Hospital and Nursing Home Probiotics Product Portfolio
- 4.6.5 Nebraska Cultures Recent Developments
- 4.7 Nutraceutix
- 4.7.1 Nutraceutix Company Information
- 4.7.2 Nutraceutix Business Overview
- 4.7.3 Nutraceutix Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Nutraceutix Hospital and Nursing Home Probiotics Product Portfolio
- 4.7.5 Nutraceutix Recent Developments
- 4.8 NutraScience Labs
- 4.8.1 NutraScience Labs Company Information
- 4.8.2 NutraScience Labs Business Overview
- 4.8.3 NutraScience Labs Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 NutraScience Labs Hospital and Nursing Home Probiotics Product Portfolio
- 4.8.5 NutraScience Labs Recent Developments
- 4.9 Probium
- 4.9.1 Probium Company Information
- 4.9.2 Probium Business Overview
- 4.9.3 Probium Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Probium Hospital and Nursing Home Probiotics Product Portfolio
- 4.9.5 Probium Recent Developments
- 4.10 Protexin
- 4.10.1 Protexin Company Information
- 4.10.2 Protexin Business Overview
- 4.10.3 Protexin Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Protexin Hospital and Nursing Home Probiotics Product Portfolio
- 4.10.5 Protexin Recent Developments
- 4.11 Rising Pharmaceuticals
- 4.11.1 Rising Pharmaceuticals Company Information
- 4.11.2 Rising Pharmaceuticals Business Overview
- 4.11.3 Rising Pharmaceuticals Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Rising Pharmaceuticals Hospital and Nursing Home Probiotics Product Portfolio
- 4.11.5 Rising Pharmaceuticals Recent Developments
- 4.12 UP4 Probiotics
- 4.12.1 UP4 Probiotics Company Information
- 4.12.2 UP4 Probiotics Business Overview
- 4.12.3 UP4 Probiotics Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 UP4 Probiotics Hospital and Nursing Home Probiotics Product Portfolio
- 4.12.5 UP4 Probiotics Recent Developments
- 4.13 Vitakem Nutraceuticals
- 4.13.1 Vitakem Nutraceuticals Company Information
- 4.13.2 Vitakem Nutraceuticals Business Overview
- 4.13.3 Vitakem Nutraceuticals Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Vitakem Nutraceuticals Hospital and Nursing Home Probiotics Product Portfolio
- 4.13.5 Vitakem Nutraceuticals Recent Developments
5 Global Hospital and Nursing Home Probiotics Market Scenario by Region
- 5.1 Global Hospital and Nursing Home Probiotics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hospital and Nursing Home Probiotics Sales by Region: 2021-2032
- 5.2.1 Global Hospital and Nursing Home Probiotics Sales by Region: 2021-2026
- 5.2.2 Global Hospital and Nursing Home Probiotics Sales by Region: 2027-2032
- 5.3 Global Hospital and Nursing Home Probiotics Revenue by Region: 2021-2032
- 5.3.1 Global Hospital and Nursing Home Probiotics Revenue by Region: 2021-2026
- 5.3.2 Global Hospital and Nursing Home Probiotics Revenue by Region: 2027-2032
- 5.4 North America Hospital and Nursing Home Probiotics Market Facts & Figures by Country
- 5.4.1 North America Hospital and Nursing Home Probiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hospital and Nursing Home Probiotics Sales by Country (2021-2032)
- 5.4.3 North America Hospital and Nursing Home Probiotics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hospital and Nursing Home Probiotics Market Facts & Figures by Country
- 5.5.1 Europe Hospital and Nursing Home Probiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hospital and Nursing Home Probiotics Sales by Country (2021-2032)
- 5.5.3 Europe Hospital and Nursing Home Probiotics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hospital and Nursing Home Probiotics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hospital and Nursing Home Probiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hospital and Nursing Home Probiotics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hospital and Nursing Home Probiotics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hospital and Nursing Home Probiotics Market Facts & Figures by Country
- 5.7.1 South America Hospital and Nursing Home Probiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hospital and Nursing Home Probiotics Sales by Country (2021-2032)
- 5.7.3 South America Hospital and Nursing Home Probiotics Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hospital and Nursing Home Probiotics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hospital and Nursing Home Probiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hospital and Nursing Home Probiotics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hospital and Nursing Home Probiotics Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hospital and Nursing Home Probiotics Sales by Type (2021-2032)
- 6.1.1 Global Hospital and Nursing Home Probiotics Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Hospital and Nursing Home Probiotics Sales Market Share by Type (2021-2032)
- 6.2 Global Hospital and Nursing Home Probiotics Revenue by Type (2021-2032)
- 6.2.1 Global Hospital and Nursing Home Probiotics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hospital and Nursing Home Probiotics Revenue Market Share by Type (2021-2032)
- 6.3 Global Hospital and Nursing Home Probiotics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hospital and Nursing Home Probiotics Sales by Application (2021-2032)
- 7.1.1 Global Hospital and Nursing Home Probiotics Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Hospital and Nursing Home Probiotics Sales Market Share by Application (2021-2032)
- 7.2 Global Hospital and Nursing Home Probiotics Revenue by Application (2021-2032)
- 7.2.1 Global Hospital and Nursing Home Probiotics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hospital and Nursing Home Probiotics Revenue Market Share by Application (2021-2032)
- 7.3 Global Hospital and Nursing Home Probiotics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hospital and Nursing Home Probiotics Value Chain Analysis
- 8.1.1 Hospital and Nursing Home Probiotics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hospital and Nursing Home Probiotics Production Mode & Process
- 8.2 Hospital and Nursing Home Probiotics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hospital and Nursing Home Probiotics Distributors
- 8.2.3 Hospital and Nursing Home Probiotics Customers
9 Global Hospital and Nursing Home Probiotics Analyzing Market Dynamics
- 9.1 Hospital and Nursing Home Probiotics Industry Trends
- 9.2 Hospital and Nursing Home Probiotics Industry Drivers
- 9.3 Hospital and Nursing Home Probiotics Industry Opportunities and Challenges
- 9.4 Hospital and Nursing Home Probiotics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst